Aspirin Versus Low-Dose Low-Molecular-Weight Heparin: Antithrombotic Therapy in Pediatric Ischemic Stroke Patients: A Prospective Follow-Up Study
Open Access
- 1 November 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (11) , 2554-2558
- https://doi.org/10.1161/hs1101.097379
Abstract
Background and Purpose— We sought to compare different antithrombotic secondary treatments (mainly medium-dose aspirin with low-dose low-molecular-weight heparin [LMWH]) in pediatric patients with a first ischemic stroke onset with regard to the risk of stroke recurrence.Keywords
This publication has 0 references indexed in Scilit: